So what's stopping us from ending AIDS?
What if the AIDS epidemic could be ended by 2030? Watch this video to learn more.
HIV and AIDS
HIV and AIDS
Back to Results
Invest in ending AIDS
US$ 29 billion a year by 2025 will provide for comprehensive HIV services, people-centred, context-specific service integration and the removal of societal and legal impediments to creating an enabling environment for HIV services. Investing fully will lead to preventing hundreds of thousands of AIDS-related deaths and averting millions of new HIV infections.
The effects of the COVID-19 pandemic on the HIV response
This graphic discusses the effects of the COVID-19 pandemic on the HIV response
20.2 million girls and women living with HIV
This infographic discusses how girls and women make up more than half of the 37.7 million people living with HIV. Ending AIDS by 2030 requires that we address girls’ and women’s diverse roles by putting them at the centre of the response.
Disease Risks and Homelessness
The recent emergence of the Coronavirus Disease (COVID-19) calls for enhanced cooperation between public health authorities, homeless service systems, and other partners at the local level. HUD strongly encourages CoCs to contact their local public health departments, Healthcare for the Homeless agencies, and other local health partners to ensure the unique needs and opportunities related to the homeless service system are incorporated in plans to prevent and respond to infectious diseases like COVID-19.
RWHAP PART B/ADAP Coordination with Medicare
This resource walks through some of the basic elements of the Medicare program and provides information to support RWHAP Part B/ADAP staff in adapting program activities to better coordinate with Medicare coverage, including providing premium and cost-sharing assistance for clients. For a more comprehensive overview of the Medicare program as well as client-facing resources, please visit the Medicare resources created as part of the Access, Care, & Engagement (ACE) Technical Assistance Center.
UNAIDS and WHO 2022 Policy Brief: Virtual interventions in response to HIV, sexually transmitted infections and viral hepatitis
This research discusses how PrEP was approved for HIV prevention in the US in 2012; uptake has been slow. Black and Hispanic people have higher rates of new HIV diagnoses than White non-Hispanic people in the US. We describe the inequitable use of PrEP by race within US regions from 2012-2021.